| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | TNFRSF13B | Synonyms | CD267, CVID, CVID2, IGAD2, RYZN, TACI, TNFRSF14B | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p11.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | TNF receptor superfamily member 13B | ||||
| GTO ID | GTC2526 |
| Trial ID | NCT04657861 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|TACI |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | APRIL CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma |
| Year | 2020 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | APRIL-001 |
| Cohort 1 | |||||||||
|
|||||||||